-
Something wrong with this record ?
Receptor subtype abundance as a tool for effective intracellular signalling
J Myslivecek, M Novakova, M Klein
Language English Country Netherlands
Document type Review
- MeSH
- Receptors, Adrenergic, beta physiology MeSH
- Models, Biological MeSH
- Financing, Organized MeSH
- Humans MeSH
- Receptors, Muscarinic physiology MeSH
- Receptors, G-Protein-Coupled physiology MeSH
- Signal Transduction physiology MeSH
- Heart physiology MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Review MeSH
The regulation of heart function is one of the essentials for the survival of organism. Therefore, the effective mechanisms of regulation can minimize the energy requirements and improve the ability to react to different needs on time and appropriately. Two receptor types, beta-adrenoceptors and muscarinic receptors, with almost antagonistic function, are "basic regulators" of the heart parameters. It is relevant to mention that beside the main adrenoceptors and muscarinic receptors subtypes (beta(1)- and M(2)-subtype), other minor subtypes that regulate heart function, i.e. beta-, beta-adrenoceptors, alpha(1)-adrenoceptors and minor subtypes of muscarinic receptors (M(1), M(3) and M(5)) are present in the heart. In this regard is intriguing that just two catecholamines (adrenaline, noradrenaline) have many "targets"--receptors that differ so much in the functional consequences of their activation: while beta(1)- and beta(2)-adrenoceptors cause cardiostimulation, beta(3)-adrenoceptors are responsible for cardioinhibition and alpha(1)-adrenoceptors contribute to enhanced inotropy. Similarly, some data show that other muscarinic receptors than M(2) muscarinic subtype, are expressed in the heart and these minor subtype(s) can contribute to the heart regulation in similar way as beta(3)-adrenoceptors to the catecholamine action. Taken together, regulation of heart function through different receptor subtypes and using homologous and heterologous regulation can represent an effective tool for coping with permanently changing environmental conditions.
- 000
- 02953naa 2200325 a 4500
- 001
- bmc10034976
- 003
- CZ-PrNML
- 005
- 20111210200444.0
- 008
- 101221s2008 ne e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Mysliveček, Jaromír, $d 1968- $7 nlk19990073583
- 245 10
- $a Receptor subtype abundance as a tool for effective intracellular signalling / $c J Myslivecek, M Novakova, M Klein
- 314 __
- $a Institute of Physiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. jmys@lf1.cuni.cz
- 520 9_
- $a The regulation of heart function is one of the essentials for the survival of organism. Therefore, the effective mechanisms of regulation can minimize the energy requirements and improve the ability to react to different needs on time and appropriately. Two receptor types, beta-adrenoceptors and muscarinic receptors, with almost antagonistic function, are "basic regulators" of the heart parameters. It is relevant to mention that beside the main adrenoceptors and muscarinic receptors subtypes (beta(1)- and M(2)-subtype), other minor subtypes that regulate heart function, i.e. beta-, beta-adrenoceptors, alpha(1)-adrenoceptors and minor subtypes of muscarinic receptors (M(1), M(3) and M(5)) are present in the heart. In this regard is intriguing that just two catecholamines (adrenaline, noradrenaline) have many "targets"--receptors that differ so much in the functional consequences of their activation: while beta(1)- and beta(2)-adrenoceptors cause cardiostimulation, beta(3)-adrenoceptors are responsible for cardioinhibition and alpha(1)-adrenoceptors contribute to enhanced inotropy. Similarly, some data show that other muscarinic receptors than M(2) muscarinic subtype, are expressed in the heart and these minor subtype(s) can contribute to the heart regulation in similar way as beta(3)-adrenoceptors to the catecholamine action. Taken together, regulation of heart function through different receptor subtypes and using homologous and heterologous regulation can represent an effective tool for coping with permanently changing environmental conditions.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a srdce $x fyziologie $7 D006321
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a beta-adrenergní receptory $x fyziologie $7 D011943
- 650 _2
- $a receptory spřažené s G-proteiny $x fyziologie $7 D043562
- 650 _2
- $a receptory muskarinové $x fyziologie $7 D011976
- 650 _2
- $a signální transdukce $x fyziologie $7 D015398
- 650 _2
- $a financování organizované $7 D005381
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Nováková, Martina. $7 _AN029770
- 700 1_
- $a Klein, Martin $7 xx0092749
- 773 0_
- $w MED00173187 $t Cardiovascular & hematological disorders drug targets $g Roč. 8, č. 1 (2008), s. 66-79 $x 1871-529X
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110223132700 $b ABA008
- 991 __
- $a 20110414150241 $b ABA008
- 999 __
- $a ok $b bmc $g 823413 $s 688840
- BAS __
- $a 3
- BMC __
- $a 2008 $b 8 $c 1 $d 66-79 $i 1871-529X $m Cardiovascular & hematological disorders drug targets $n Cardiovasc Hematol Disord Drug Targets $x MED00173187
- LZP __
- $a 2011-2B/ewme